mediaTUM
Universitätsbibliothek
Technische Universität München
User: Guest
Login
de
en
All data
Titel
Autor
Jahr
All data
Titel
Autor
Jahr
All data
Titel
Autor
Jahr
More Searchfields
Reset
Search
Simple search
mediaTUM Content
University Bibliography
Electronic Examination Papers
Open Access Publikationen
Research Data
TUM.University Press
Collections
Projects
Institutions
Research Centers
TUM Board of Management
Functional Units
Partnerschaftliche Einrichtungen
Schools
TUM School of Computation, Information and Technology
(45585)
TUM School of Engineering and Design
Center of Life and Food Sciences Weihenstephan
TUM School of Management
TUM School of Medicine and Health
Deanery
(6)
Examination Papers
(6016)
Departments
(47776)
2012
(29)
2013
(23)
2014
(25)
2015
(18)
2016
(9)
2017
(12)
2018
(6)
2019
(17)
2020
(25)
2021
(25)
2022
(37)
2023
(3)
Clinical Medicine
(37131)
Institute of General Medicine (Prof. Schneider)
(322)
Institute of Radiology (Prof. Makowski)
(3542)
Institute of Experimental Hematology (Prof. Schmidt-Supprian)
(51)
Institute of Experimental Neuroimmunology (Prof. Korn)
(1)
Institute of Exerimentelle Tumortherapie (Prof. Saur)
(140)
2019
(1)
Chair of Translational Tumor Research (DKTK) (Prof. Saur)
(139)
2022
(29)
2018
(30)
2017
(12)
2019
(16)
2020
(21)
2021
(31)
Institute of Human Genetics (Prof. Winkelmann)
(1155)
Institute of AI and Informatics in Medicine (Prof. Rückert)
(1752)
Institute of Clinical Chemistry and Pathobiochemistry (Prof. Ruland)
(452)
Institute of Molecular Allergology (Prof. Schmidt-Weber)
(692)
Institute of Molecular Immunology (Prof. Knolle)
(139)
Institute of Molecular Oncology and Functional Genomics (Prof. Rad)
(136)
Department of Anesthesiology and Intensive Care (Prof. Schneider)
(828)
Clinic of Nutritional Medicine (Prof. Hauner)
(629)
Department of Ophthalmology
(357)
Department of Surgery (Prof. Friess)
(1707)
Department of Dermatology and Allergology (Prof. Biedermann)
(2203)
Department of Gynecology (Prof. Kiechle)
(1533)
Department of Otolaryngology (Prof. Wollenberg)
(629)
Department of Internal Medicine I - Cardiology (Prof. Laugwitz)
(1605)
Department of Internal Medicine II - Gastroenterology (Prof. Schmid)
(2477)
Department of Internal Medicine III - Hematology and Medical Oncology (Prof. Bassermann)
(1413)
Department of Pediatric Medicine (Prof. Hauer)
(1103)
Department of Oral and Maxillofacial Surgery (Prof. Wolff)
(483)
Clinic and Polyclinic for Neonatology (Prof. Peters komm.)
(6)
Department of Neurosurgery (Prof. Meyer)
(762)
Department of Neurology (Prof. Hemmer)
(2488)
Department of Nuclear Medicine (Prof. Weber)
(1891)
Department of Orthopedics and Sports Orthopedics (Prof. von Eisenhart-Rothe)
(1005)
Department of Plastic Surgery and Hand Surgery (Prof. Machens)
(473)
Department of Psychiatry and Psychotherapy (Prof. Priller)
(1872)
Department of Psychosomatic Medicine and Psychotherapy (Prof. Henningsen)
(1065)
Department of Radiooncology and Radiation Therapy (Prof. Combs)
(1613)
Department of Trauma Surgery (Prof. Biberthaler)
(780)
Department of Urology (Prof. Gschwend)
(1073)
Clinic and Polyclinic for Vascular and Endovascular Surgery (Prof. Eckstein)
(693)
German Heart Centre Munich
(3188)
Department of Preventive Sports Medicine and Sports Cardiology (Prof. Halle)
(517)
Weitere Lehrstühle und Professuren Clinical Medicine
(181)
Health and Sport Sciences
Preclinical Medicine
(5432)
Interdisziplinäres Zentrum für Zelltherapie
Roman Herzog Comprehensive Cancer Center
(206)
School Office
Zentrum für Präklinische Forschung
Ehemalige Einrichtungen
(2180)
TUM School of Natural Sciences
(14655)
TUM School of Social Sciences and Technology
(9048)
TUM Campus Straubing für Biotechnologie und Nachhaltigkeit
Service Facilities
TUM Institute for LifeLong Learning
Central Administration
mediaTUM Gesamtbestand
Einrichtungen
Schools
TUM School of Medicine and Health
Departments
Clinical Medicine
Institut für Experimentelle Tumortherapie (Prof. Saur)
Lehrstuhl für Translationale Tumorforschung (DKTK) (Prof. Saur)
Back
Back to start of result list
Permanent link for displayed object
Title:
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
Document type:
Journal Article
Author(s):
Muckenhuber, Alexander; Berger, Anne Katrin; Schlitter, Anna Melissa; Steiger, Katja; Konukiewitz, Björn; Trumpp, Andreas; Eils, Roland; Werner, Jens; Friess, Helmut; Esposito, Irene; Klöppel, Günter; Ceyhan, Güralp O; Jesinghaus, Moritz; Denkert, Carsten; Bahra, Marcus; Stenzinger, Albrecht; Sprick, Martin R; Jäger, Dirk; Springfeld, Christoph; Weichert, Wilko
Abstract:
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is associated with a dismal prognosis and poor therapeutic response to current chemotherapy regimens in unselected patient populations. Recently, it has been shown that PDAC may be stratified into functionally and therapeutically relevant molecular subgroups and that some of these subtypes can be recapitulated by IHC for KRT81 [quasi-mesenchymal (QM)/squamous/basal-like] and HNF1A (non-QM, overlap with exocrine/ADEX subtype).Experimental Design: We validated the different outcome of the HNF1A/KRT81 PDAC subtypes in two independent cohorts of surgically treated patients and examined the treatment response to chemotherapy in a third cohort of unresectable patients. The first two cohorts included 262 and 130 patients, respectively, and the third independent cohort comprised advanced-stage PDAC patients who were treated with either FOLFIRINOX (64 patients) or gemcitabine (61 patients).Results: In both cohorts with resected PDAC, the HNF1A-positive subtype showed the best, the KRT81-positive subtype the worst, and the double-negative subtype an intermediate survival (P < 0.013 and P < 0.009, respectively). In the chemotherapy cohort, the survival difference between the double-negative and the HNF1A-positive subtype was lost, whereas the dismal prognosis of KRT81-positive PDAC patients was retained (P < 0.021). Patients with a KRT81-positive subtype did not benefit from FOLFIRINOX therapy, whereas those with HNF1A-positive tumors responded better compared with gemcitabine-based treatment (P < 0.038).Conclusions: IHC stratification recapitulating molecular subtypes of PDAC using HNF1A and KRT81 is associated with significantly different outcomes and responses to chemotherapy. These results may pave the way toward future pretherapeutic biomarker-based stratification of PDAC patients. Clin Cancer Res; 24(2); 351-9. ©2017 AACR.
Journal title abbreviation:
Clin Cancer Res
Year:
2018
Journal volume:
24
Journal issue:
2
Pages contribution:
351-359
Language:
eng
Fulltext / DOI:
doi:10.1158/1078-0432.CCR-17-2180
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/29101303
Print-ISSN:
1078-0432
TUM Institution:
Chirurgische Klinik und Poliklinik; Institut für Allgemeine Pathologie und Pathologische Anatomie
BibTeX
Occurrences:
mediaTUM Gesamtbestand
Einrichtungen
Schools
TUM School of Medicine and Health
Departments
Clinical Medicine
Institut für Experimentelle Tumortherapie (Prof. Saur)
Lehrstuhl für Translationale Tumorforschung (DKTK) (Prof. Saur)
2018
mediaTUM Gesamtbestand
Einrichtungen
Schools
TUM School of Medicine and Health
Departments
Clinical Medicine
Klinik und Poliklinik für Chirurgie (Prof. Friess)
2018
mediaTUM Gesamtbestand
Einrichtungen
Schools
TUM School of Medicine and Health
Departments
mediaTUM Gesamtbestand
Hochschulbibliographie
2018
Fakultäten
Medizin
Institut für Allgemeine Pathologie und Pathologische Anatomie
mediaTUM Gesamtbestand
Einrichtungen
Schools
TUM School of Medicine and Health
Departments
Preclinical Medicine
Institut für Allgemeine Pathologie und Pathologische Anatomie (Dr. Mogler komm.)
2018